Trial Number

303-22

Condition

Cystic Fibrosis

Participant Age Range

6 years and older

Participant Gender

Any

Enrolling Participants

Yes

Overview

Standardizing Treatments for Pulmonary Exacerbations: A platform for evaluating treatment decisions to improve outcomes (STOP360)

Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study.

Related Clinical Trials

Click on the category you are interested in.

Name
Enter Trial number from the area just below the marquee.
How would you prefer to be contacted?
How did you hear about us?
This registration is for:
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.